Statera Biopharma, Inc. Financial and Nonfinancial Liabilities, Fair Value Disclosure
Statera Biopharma, Inc. had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $5.31 million as of 2015-09-30, per its 10-Q filed 2015-11-09.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2015-11-09
- 2015-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $5.31M.
- 2015-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $5.36M.
- 2015-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $4.68M.
- 2014-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $994.37K.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2015-09-30 | $5.31M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $5.36M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $4.68M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $994.37K 10-Q · filed 2015-11-09 |
| 2014-09-30 | $1.86M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $1.02M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $1.44M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $1.55M 10-K · filed 2015-02-27 |
| 2013-09-30 | $3.76M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $4.82M 10-Q · filed 2013-08-09 |
| 2012-12-31 | $4.11M 10-K · filed 2014-03-17 |
| 2012-06-30 | $4.11M 10-Q · filed 2013-08-09 |